Prostate cancer (PC) is the third-leading cause of cancer-related deaths worldwide.
Although the current treatment strategies are progressing rapidly, PC is still representing a …

Simple Summary Prostate cancer (PCa) is a widespread malignancy, representing the
second leading cause of cancer-related death in men. In the last years, liquid biopsy has …

Prostate cancer (PCa) is one of the most commonly diagnosed cancers among men
worldwide. Despite the presence of accumulated clinical strategies for PCa management …

Mammalian target of rapamycin (mTOR) regulates various fundamental cellular events
including cell proliferation, protein synthesis, metabolism, apoptosis, and autophagy. Tumor …

Altered expression of microRNA-182-5p (miR-182) has been consistently linked with many
cancers, but its specific role in prostate cancer remains unclear. In particular, its contribution …

Extracellular vesicles (EVs) play an important role in the diagnosis and treatment of
diseases because of their rich molecular contents involved in intercellular communication …

Non-small cell lung cancer (NSCLC) comprises 85% of all lung cancers and is a malignant
condition resistant to advanced-stage treatment. Despite the advancement in detection and …

Simple Summary Accumulating studies have highlighted the critical roles of microRNAs in
tumorigenesis and cancer treatment responses. Here, we systematically review the scientific …

Prostate cancer (PCa) is one of the most prominent causes of cancer‑related mortality in the
male population. A highly impactful prognostic factor for patients diagnosed with PCa is the …

Prostate cancer (PCa) is considered one of the most prevalent male malignancies
worldwide with a global burden estimated to increase over the next two decades. Due to …